FDA panel votes against MDMA for PTSD, setting up hurdle to approval



FDA advisers cited a variety of concerns with the trials submitted by Lykos Therapeutics as part of the application.



, 2024-06-04 23:53:33

Source link

Related posts

From Likes to Loss: How Four Instagram Posts Turned Her World Upside Down” – The New York Times

Pennsylvania Showdown: Republicans Rally with Optimism as Democrats Express Concerns

Neck-and-Neck in the Polls: Will the Results Tell a Different Story?

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More